The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 14, 2023

Filed:

May. 21, 2019
Applicant:

Janssen Biotech, Inc., Horsham, PA (US);

Inventors:

Francois Gaudet, Princeton, NJ (US);

Jill Giles-Komar, Downingtown, PA (US);

Bradley Heidrich, Gilbertsville, PA (US);

Chichi Huang, Malvern, PA (US);

Colleen Kane, Flourtown, PA (US);

Ronan McDaid, Eagleville, PA (US);

Jennifer Nemeth-Seay, Fort Washington, PA (US);

Assignee:

JANSSEN BIOTECH, INC., Horsham, PA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61P 35/00 (2006.01); A61K 39/395 (2006.01); C07K 16/30 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2809 (2013.01); A61K 39/39541 (2013.01); A61P 35/00 (2018.01); C07K 16/28 (2013.01); C07K 16/2803 (2013.01); C07K 16/3069 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/55 (2013.01); C07K 2317/92 (2013.01);
Abstract

The present invention relates to antibodies that specifically bind CD3. The present invention relates to antibodies that specifically bind PSMA. The present invention relates to antibodies that specifically bind CD3 and PSMA. The present invention relates to antibodies that specifically bind IL1RAP. The present invention relates to antibodies that specifically bind CD33. The present invention relates to antibodies that specifically bind CD3 and IL1RAP. The present invention relates to antibodies that specifically bind CD3 and CD33. The present invention relates to antibodies that specifically bind TMEFF2. The present invention relates to antibodies that specifically bind CD3 and TMEFF2. The present invention relates to fragments of the antibodies, polynucleotides encoding the antibodies or fragments thereof, and methods of making and using the same.


Find Patent Forward Citations

Loading…